MedTrace Logo

Electrophysiologically Guided PAcing Site Selection Study

NCT00239226 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2013-11-25

Study results available
· View outcomes & findings →

Summary

This study is a long-term, prospective, and controlled evaluation of the incidence of persistent atrial fibrillation (AF) in patients with severe intra-right atrial conduction delay paced with preventive algorithms at the interatrial septum (IAS) versus right atrial appendage (RAA).

Conditions

Interventions

PROCEDURE

IAS pacing - study group

site of implant and permanent pacing

PROCEDURE

IAS pacing control group

site of implant and permanent pacing

PROCEDURE

Pacing RAA study group

site of implant and permanent pacing

PROCEDURE

Pacing RAA control group

site of implant and permanent pacing

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic BRC

    lead INDUSTRY

Principal Investigators

  • Giorgio Corbucci, PhD · Medtronic

  • Roberto Verlato, MD · Camposampiero Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2008-12-31
Completion
2009-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00239226 on ClinicalTrials.gov